Robert L. Avery
Impact in
- Ophthalmology top 0.02%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Ocular Infections and Treatments
-
- Retinal and Macular Surgery
- Retinopathy of Prematurity Studies
Papers in
-
- Retinal Diseases and Treatments 67
- Ocular Infections and Treatments 5
- Intraocular Surgery and Lenses 3
- Glaucoma and retinal disorders 3
-
- Retinal and Macular Surgery 19
- Retinopathy of Prematurity Studies 3
- Co-authors
- Dante J. Pieramici (28 shared papers)ALESSANDRO A. CASTELLARIN (22 shared papers)Ma'an A. Nasir (18 shared papers)Melvin Rabena (18 shared papers)Lloyd Paul Aiello (4 shared papers)Paul G. Arrigg (3 shared papers)Matthew J. Giust (4 shared papers)Hagen Thieme (2 shared papers)
- Journals
- Retina (18 papers)Investigative Ophthalmology & Visual Science (15 papers)Ophthalmology (11 papers)Ophthalmology Retina (4 papers)Ophthalmic surgery, lasers & imaging retina (4 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Robert L. Avery
87 papers receiving 10.7k citations
Robert L. Avery's Hit Papers
Peers
Comparison fields: 5 of 114
- Ophthalmology 8.3k
- Radiology, Nuclear Medicine and Imaging 2k
- Pharmaceutical Science 270
- Molecular Biology 2k
- Clinical Biochemistry 98
Countries citing papers authored by Robert L. Avery
This map shows the geographic impact of Robert L. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Avery more than expected).
Fields of papers citing papers by Robert L. Avery
This network shows the impact of papers produced by Robert L. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Avery. The network helps show where Robert L. Avery may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders Hit paper breakdown → | 1994 | 3268 |
| 2 | Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration Hit paper breakdown → | 2006 | 1014 |
| 3 | Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Hit paper breakdown → | 1995 | 930 |
| 4 | Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy Hit paper breakdown → | 2006 | 672 |
| 5 | 2007 | 339 | |
| 6 | Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials Hit paper breakdown → | 2023 | 319 |
| 7 | 2006 | 310 | |
| 8 | Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD Hit paper breakdown → | 2014 | 310 |
| 9 | 2007 | 299 | |
| 10 | 2018 | 297 | |
| 11 | 2006 | 296 | |
| 12 | 1996 | 283 | |
| 13 | SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB Hit paper breakdown → | 2017 | 271 |
| 14 | 2014 | 212 | |
| 15 | 2007 | 209 | |
| 16 | 2015 | 183 | |
| 17 | 2015 | 178 | |
| 18 | 2008 | 162 | |
| 19 | The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results Hit paper breakdown → | 2023 | 132 |
| 20 | 2015 | 95 |
About Robert L. Avery
Robert L. Avery is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Pharmaceutical Science, Molecular Biology and Family Practice, having authored 92 papers that have together received 11.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (67 papers), Retinal and Macular Surgery (19 papers), Ocular Infections and Treatments (5 papers), Advanced Drug Delivery Systems (4 papers), Retinal Development and Disorders (4 papers), Intraocular Surgery and Lenses (3 papers), Retinopathy of Prematurity Studies (3 papers) and Glaucoma and retinal disorders (3 papers). The work is most often cited by research in Ophthalmology (8.3k citations), Radiology, Nuclear Medicine and Imaging (2k citations), Pharmaceutical Science (270 citations), Molecular Biology (2k citations) and Clinical Biochemistry (98 citations). Robert L. Avery has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Dante J. Pieramici, ALESSANDRO A. CASTELLARIN, Ma'an A. Nasir, Melvin Rabena, Lloyd Paul Aiello, Paul G. Arrigg, Matthew J. Giust, Hagen Thieme, Louis Robert Pasquale and Bruce A. Keyt. Their work appears in journals such as Retina, Investigative Ophthalmology & Visual Science, Ophthalmology, Ophthalmology Retina and Ophthalmic surgery, lasers & imaging retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.